Alpha Articles
Ulcerative colitis drug market will nearly double to $2.1 billion in 2018 in top seven markets
15 February 2010
Increasing competition from other biologics will continue to erode Enbrel's dominance in the psoriasis drug market, DR report concludes
12 February 2010
UK Appeal Court invalidates HGS/GlaxoSmithKline lupus drug patent; Simcere cleared to manufacture and sell zanamivir in China
11 February 2010
Larger proportion of hepatitis C non-responder patients in USA will get telaprevir therapy than boceprevir, study shows
20 January 2010
Sharp rise in US FDA approvals of biopharmaceuticals in 2009, highest since 2005, says BII
18 January 2010
FDA finally approves Roche’s Actemra for moderately-to-severely active rheumatoid arthritis
11 January 2010
CRT grants rights for targeting technology to Aura
24 December 2009
Merck & Co - now world’s No 2 drugmaker - upbeat about new operation post Schering-Plough merger; but what about J&J?
5 November 2009
Biosimilars of TNF-alpha inhibitors stand to erode over $9 billion in brand sales in USA and Europe by 2018
4 November 2009
Novartis buys back exclusive US/Canada rights from Vanda Pharmaceuticals for Fanapt in deal worth up to $465 million
13 October 2009
$4 million milestone for Ablynx in Nanobody deal with Wyeth
1 October 2009
US FDA approves Shire’s ADHD drug Intuniv
4 September 2009
Is GlaxoSmithKline eyeing a $4 billion bid for Human Genome?
26 August 2009
Aileron closes $40M financing
9 June 2009
Amarillo enrolls 60 in Ph II interferon study
1 June 2009
Intuniv cuts symptoms in ADHD children
26 May 2009
AnaMar initiates clinical trials of oral RA drug
22 May 2009
Solvay viewing options for pharma
21 May 2009
Sutent recommended as UK 1st-line mRCC drug
18 May 2009
Strong interest in J&J's Simponi
13 May 2009
Debiopharm hails strong results with HCV drug
28 April 2009
FDA appro for J&J arthritis drug Simponi
28 April 2009
Locteron shows better AE profile than PEG-Intron
24 April 2009
J&J 1st qtr hit by market drop; keeps guidance
15 April 2009
Japan stock market week to April 13, 2009
14 April 2009
Watson's Rapaflo launched in USA
8 April 2009
FDA expands indication for S-P hep C combo
30 March 2009
Probiotics show benefit for immune system
30 March 2009
Additional Actos indication for Takeda
30 March 2009
New guidelines to help boost use of 5-ARIs
9 March 2009
ExonHit looking to partner novel AD drug
9 March 2009
Cephalon bids $205M for Australia's Arana
9 March 2009
Wafergen updates on SmartChip program
2 March 2009
Defyrus buys UK gov't biowarfare patents
2 March 2009
Amarillo hep C agent cleared for Ph II in Taiwan
23 February 2009
Positive results for EnVivo's EVP-6124
26 January 2009
Stock Commentary - Europe - week to Jan 19, 2009
26 January 2009
Daiichi Sankyo files for approval of silodosin in China
19 January 2009
Japan stock market week to Jan 12, 2009
19 January 2009
ESBATech's OA drug enters Ph I/IIa trial
19 January 2009
Memory doses first schizophrenia patient in trial
12 January 2009
ASH hears strong data on Novartis
22 December 2008
86% of leukemia patients still alive after 7 years with Glivec
15 December 2008
Danish Biomonitor acquires Neutekbio
8 December 2008
Roche signs deal to buy Memory for $50M cash
1 December 2008
BioSante gets NIH grant for inhaled interferon
24 November 2008
Lasting benefits of CEL-SCI's RA vaccine demonstrated
24 November 2008
GenVac gets FDA Fast Track for TNFerade
17 November 2008
Expanded European indication for Roche's Pegasys/Copegus
8 November 2008
Cytheris' CYT107 enters Ph I/IIa trial
3 November 2008
Kamada completes Ph III trial of AAT therapy
3 November 2008
Addrenex initiates Ph II ADX415 study
3 November 2008
Arrowhead says Calando is "attractive"acquisition target
27 October 2008
Japan stock market week to Oct 20, 2008
27 October 2008
Humira shows three year fistula effect
27 October 2008
Resveratrol could cut alcoholism liver damage
27 October 2008
Genentech refuses to comment on Roche merger
20 October 2008
Newron granted European patent for safinamide in RLS
20 October 2008
Kamada's ATT system does well in Ph II
20 October 2008
Watson's Rapaflo approved by US FDA
13 October 2008
Helix private placement to total C$11.4M
6 October 2008
Helix cleared to test topical interferon alpha-2B in Germany
29 September 2008
Roche decides to expand Ph II CIAS trial
29 September 2008
Sanofi initiates Ph II trial of melanoma vacc
29 September 2008
Three Rivers gets expanded rights to Infergen
22 September 2008
Pfizer economic study says Sutent cost effective in mRCC
22 September 2008
Cognis starts making vitamin E TPGS aimed at pharmaceutical sector
22 September 2008
Biogen and Elan start testing Tysabri in first cancer setting with Ph I/II trial in MM
15 September 2008
US FDA calls for tougher warnings on TNF-alpha drugs on 240 cases of histoplasmosis
15 September 2008
Japan stock market week to August 25, 2008
1 September 2008
Boehringer extends Ablynx AD accord
1 September 2008
Orphan status for Santhera's Omigapil
1 September 2008
Protherics rockets on bid approaches
1 September 2008
ESBATech raises $22M in extended series B round
18 August 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
